Table 4 Distribution of baseline values of potential effect modifiers within each intervention group
MT (N = 122) | Non-MT (N = 116) | |||
|---|---|---|---|---|
n | % | n | % | |
SP six months before inclusion | ||||
< =20% of time | 103 | 84% | 86 | 74% |
> 20% of time | 6 | 5% | 16 | 14% |
Missing | 13 | 11% | 14 | 12% |
CMP six months before inclusion | ||||
< =20% of time | 98 | 80% | 88 | 76% |
> 20% of time | 11 | 9% | 14 | 12% |
Missing | 13 | 11% | 14 | 12% |
EoCC | ||||
Better | 73 | 60% | 73 | 63% |
Worse/same | 6 | 5% | 6 | 5% |
Missing | 43 | 35% | 37 | 32% |
NRS baseline | ||||
< =7 | 111 | 91% | 108 | 93% |
> 7 | 11 | 9% | 8 | 7% |
Missing | 0 | 0% | 0 | 0% |
KID | ||||
High QOL | 113 | 93% | 103 | 89% |
Low QOL | 9 | 7% | 12 | 10% |
Missing | 0 | 0% | 1 | 1% |